FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387476739> ?p ?o ?g. }

• W4387476739 endingPage "S128" @default.
• W4387476739 startingPage "S127" @default.
• W4387476739 abstract "Metabolite measurements from the cerebrospinal fluid (CSF) have been employed as diagnostic tools for neurodegenerative disorders, such as Alzheimer's disease (AD). AD's pathogenesis is identified by lowered measured levels of CSF amyloid Beta 1-42 (AB), and increased levels of phosphorylated tau (pTau) and total tau (tTau). Due to their direct contact with the brain, metabolites from the CSF are relatively close to these phenotypes and could be used to study biological pathways and signatures associated with neurological disorders. Furthermore, CSF metabolites could help elucidate the effect of the genetic architecture of these disorders, as genome wide association studies (GWAS) have shown that metabolic features can have a heritable component. While the APOE e4 allele has been implicated as the main AD risk locus, other sites of the genome have been found to be associated with AD, indicating a complex, polygenic architecture. Therefore, CSF metabolites are suitable to identify biological pathways impacted by both AD genetic factors and its hallmark biomarkers. For this purpose, we collected more than 5,000 CSF metabolite measurements from AD and mild cognitive impairment patients, and healthy individuals from the Amsterdam Dementia cohort (ADC), as well as imputed genotype data. Using the most recent AD GWAS to calculate a polygenic risk score (PRS) for AD that adds the effect of the APOE alleles as a weighted sum, we found a modest prediction of pTau and tTau by the PRS in linear models after correcting for age and sex, however this effect was mainly driven by APOE e4 allele counts, and is smaller in comparison to the large effect size that is seen for AB. No CSF metabolites were found to be significantly predicted by the PRS or APOE e4 allele counts. We then used an elastic net model to predict AD biomarkers levels using the measured CSF metabolites. This approach identified 18 and 20 metabolites that predicted CSF pTau and CSF tTau levels respectively, among them Cholesterol, Isothreonic acid, and Nicotinoylglycine. Within these CSF metabolites, we did not find any that predicted CSF AB levels. These results indicate that these biomarkers show independent, but biologically correlated aspects of AD pathogenesis. AB reflects the influence of the APOE e4 allele while pTau and tTau are associated with ongoing cellular processes. This is consistent with prior reports that sporadic AD pathogenesis could be driven by a dual-cascade. Further analysis on a separate cohort of healthy individuals, in which the same CSF metabolites were measured, is currently ongoing to replicate these results." @default.
• W4387476739 created "2023-10-11" @default.
• W4387476739 creator A5002334449 @default.
• W4387476739 creator A5003743615 @default.
• W4387476739 creator A5019046283 @default.
• W4387476739 creator A5022855713 @default.
• W4387476739 creator A5028505510 @default.
• W4387476739 creator A5029875703 @default.
• W4387476739 creator A5030923361 @default.
• W4387476739 creator A5038926287 @default.
• W4387476739 creator A5040312306 @default.
• W4387476739 creator A5057540991 @default.
• W4387476739 creator A5075394738 @default.
• W4387476739 creator A5078911264 @default.
• W4387476739 date "2023-10-01" @default.
• W4387476739 modified "2023-10-16" @default.
• W4387476739 title "W45. PREDICTION OF ALZHEIMER'S DISEASE BIOMARKERS USING GENOMICS AND CEREBROSPINAL FLUID METABOLOMICS" @default.
• W4387476739 doi "https://doi.org/10.1016/j.euroneuro.2023.08.233" @default.
• W4387476739 hasPublicationYear "2023" @default.
• W4387476739 type Work @default.
• W4387476739 citedByCount "0" @default.
• W4387476739 crossrefType "journal-article" @default.
• W4387476739 hasAuthorship W4387476739A5002334449 @default.
• W4387476739 hasAuthorship W4387476739A5003743615 @default.
• W4387476739 hasAuthorship W4387476739A5019046283 @default.
• W4387476739 hasAuthorship W4387476739A5022855713 @default.
• W4387476739 hasAuthorship W4387476739A5028505510 @default.
• W4387476739 hasAuthorship W4387476739A5029875703 @default.
• W4387476739 hasAuthorship W4387476739A5030923361 @default.
• W4387476739 hasAuthorship W4387476739A5038926287 @default.
• W4387476739 hasAuthorship W4387476739A5040312306 @default.
• W4387476739 hasAuthorship W4387476739A5057540991 @default.
• W4387476739 hasAuthorship W4387476739A5075394738 @default.
• W4387476739 hasAuthorship W4387476739A5078911264 @default.
• W4387476739 hasConcept C104317684 @default.
• W4387476739 hasConcept C106208931 @default.
• W4387476739 hasConcept C126322002 @default.
• W4387476739 hasConcept C135763542 @default.
• W4387476739 hasConcept C153209595 @default.
• W4387476739 hasConcept C180754005 @default.
• W4387476739 hasConcept C186413461 @default.
• W4387476739 hasConcept C21565614 @default.
• W4387476739 hasConcept C2777477808 @default.
• W4387476739 hasConcept C2779134260 @default.
• W4387476739 hasConcept C2779483572 @default.
• W4387476739 hasConcept C2779651940 @default.
• W4387476739 hasConcept C502032728 @default.
• W4387476739 hasConcept C54355233 @default.
• W4387476739 hasConcept C57089818 @default.
• W4387476739 hasConcept C60644358 @default.
• W4387476739 hasConcept C71924100 @default.
• W4387476739 hasConcept C81941488 @default.
• W4387476739 hasConcept C84597430 @default.
• W4387476739 hasConcept C86803240 @default.
• W4387476739 hasConcept C9287583 @default.
• W4387476739 hasConceptScore W4387476739C104317684 @default.
• W4387476739 hasConceptScore W4387476739C106208931 @default.
• W4387476739 hasConceptScore W4387476739C126322002 @default.
• W4387476739 hasConceptScore W4387476739C135763542 @default.
• W4387476739 hasConceptScore W4387476739C153209595 @default.
• W4387476739 hasConceptScore W4387476739C180754005 @default.
• W4387476739 hasConceptScore W4387476739C186413461 @default.
• W4387476739 hasConceptScore W4387476739C21565614 @default.
• W4387476739 hasConceptScore W4387476739C2777477808 @default.
• W4387476739 hasConceptScore W4387476739C2779134260 @default.
• W4387476739 hasConceptScore W4387476739C2779483572 @default.
• W4387476739 hasConceptScore W4387476739C2779651940 @default.
• W4387476739 hasConceptScore W4387476739C502032728 @default.
• W4387476739 hasConceptScore W4387476739C54355233 @default.
• W4387476739 hasConceptScore W4387476739C57089818 @default.
• W4387476739 hasConceptScore W4387476739C60644358 @default.
• W4387476739 hasConceptScore W4387476739C71924100 @default.
• W4387476739 hasConceptScore W4387476739C81941488 @default.
• W4387476739 hasConceptScore W4387476739C84597430 @default.
• W4387476739 hasConceptScore W4387476739C86803240 @default.
• W4387476739 hasConceptScore W4387476739C9287583 @default.
• W4387476739 hasLocation W43874767391 @default.
• W4387476739 hasOpenAccess W4387476739 @default.
• W4387476739 hasPrimaryLocation W43874767391 @default.
• W4387476739 hasRelatedWork W1971424770 @default.
• W4387476739 hasRelatedWork W2066467839 @default.
• W4387476739 hasRelatedWork W2111842731 @default.
• W4387476739 hasRelatedWork W2754869062 @default.
• W4387476739 hasRelatedWork W2923859939 @default.
• W4387476739 hasRelatedWork W2982417329 @default.
• W4387476739 hasRelatedWork W2986919234 @default.
• W4387476739 hasRelatedWork W3098014387 @default.
• W4387476739 hasRelatedWork W3195469724 @default.
• W4387476739 hasRelatedWork W4363648506 @default.
• W4387476739 hasVolume "75" @default.
• W4387476739 isParatext "false" @default.
• W4387476739 isRetracted "false" @default.
• W4387476739 workType "article" @default.